Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies

14 Jun 2016

Abstract excerpt

// Elisabetta Fratta 1 , Barbara Montico 1 , Aurora Rizzo 1 , Francesca Colizzi 1 , Luca Sigalotti 1 and Riccardo Dolcetti 1,2 1 Cancer Bio-Immunotherapy Unit, Centro di Riferimento Oncologico, IRCCS, National Cancer Institute, Aviano, PN, Italy 2 University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia Correspondence to: Riccardo Dolcetti, email: // Keywords :...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Epigenetics and DNA Methylation
Share to Histone Deacetylase Inhibitors Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27329599
DOI: 10.18632/oncotarget.10033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapiesPMID 27329599Read ↗

Epigenetic therapy in hematological cancersSemantic proximity Read ↗

The DNA methylation landscape of hematological malignancies: an updateSemantic proximity Read ↗

Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: What can be learned from hematologic malignancies?Semantic proximity Read ↗

Epigenetics in the hematologic malignanciesSemantic proximity Read ↗

Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic ToolSemantic proximity Read ↗

Epigenetic deregulation in myeloid malignanciesSemantic proximity Read ↗

Current and emerging molecular and epigenetic disease entities in acute myeloid leukemia and a critical assessment of their therapeutic modalitiesSemantic proximity Read ↗

Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignanciesSemantic proximity Read ↗

The Impact of Epigenetic Modifications in Myeloid MalignanciesSemantic proximity Read ↗

The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasmsSemantic proximity Read ↗

Epigenetics and OncologySemantic proximity Read ↗

Epigenetics of hematopoiesis and hematological malignancies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.